Literature DB >> 29599202

MYD88 mutated and wild-type Waldenström's Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4.

Maria Luisa Guerrera1,2,3, Nickolas Tsakmaklis1, Lian Xu1, Guang Yang1,2, Maria Demos1, Amanda Kofides1, Gloria G Chan1, Robert J Manning1, Xia Liu1, Jiaji G Chen1, Manit Munshi1, Christopher J Patterson1, Jorge J Castillo1,2, Toni Dubeau1, Joshua Gustine1, Ruben D Carrasco4,5, Luca Arcaini3,6, Marzia Varettoni3, Mario Cazzola3,6, Steven P Treon1,2, Zachary R Hunter7,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29599202      PMCID： PMC6119142          DOI： 10.3324/haematol.2018.190181

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Authors:  Roger G Owen; Steven P Treon; Ayad Al-Katib; Rafael Fonseca; Philip R Greipp; Mary L McMaster; Enrica Morra; Gerassimos A Pangalis; Jesus F San Miguel; Andrew R Branagan; Meletios A Dimopoulos
Journal:  Semin Oncol       Date:  2003-04       Impact factor: 4.929

2.  Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia.

Authors:  Stéphanie Poulain; Christophe Roumier; Sylvie Galiègue-Zouitina; Agnès Daudignon; Charles Herbaux; Rachid Aiijou; Amélie Lainelle; Natacha Broucqsault; Elisabeth Bertrand; Salomon Manier; Aline Renneville; Valérie Soenen; Sabine Tricot; Catherine Roche-Lestienne; Patrick Duthilleul; Claude Preudhomme; Bruno Quesnel; Pierre Morel; Xavier Leleu
Journal:  Am J Hematol       Date:  2013-08-30       Impact factor: 10.047

3.  MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance.

Authors:  Marzia Varettoni; Silvia Zibellini; Luca Arcaini; Emanuela Boveri; Sara Rattotti; Cristiana Pascutto; Silvia Mangiacavalli; Manuel Gotti; Lara Pochintesta; Marco Paulli; Mario Cazzola
Journal:  Blood       Date:  2013-09-26       Impact factor: 22.113

4.  MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival.

Authors:  Steven P Treon; Joshua Gustine; Lian Xu; Robert J Manning; Nicholas Tsakmaklis; Maria Demos; Kirsten Meid; Maria L Guerrera; Manit Munshi; Gloria Chan; Jiaji Chen; Amanda Kofides; Christopher J Patterson; Guang Yang; Xia Liu; Patricia Severns; Toni Dubeau; Zachary R Hunter; Jorge J Castillo
Journal:  Br J Haematol       Date:  2017-11-27       Impact factor: 6.998

5.  The cellular origin and malignant transformation of Waldenström macroglobulinemia.

Authors:  Bruno Paiva; Luis A Corchete; Maria-Belen Vidriales; Ramón García-Sanz; Jose J Perez; Irene Aires-Mejia; Maria-Luz Sanchez; Paloma Barcena; Diego Alignani; Cristina Jimenez; Maria-Eugenia Sarasquete; María-Victoria Mateos; Enrique M Ocio; Noemi Puig; Fernando Escalante; José Hernández; Rebeca Cuello; Alfonso García de Coca; Magdalena Sierra; Maria-Carmen Montes; Tomás J González-López; Josefina Galende; Abelardo Bárez; José Alonso; Emilia Pardal; Alberto Orfao; Norma C Gutierrez; Jesús F San Miguel
Journal:  Blood       Date:  2015-02-05       Impact factor: 22.113

6.  Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.

Authors:  Matthew S Davids; Andrew W Roberts; John F Seymour; John M Pagel; Brad S Kahl; William G Wierda; Soham Puvvada; Thomas J Kipps; Mary Ann Anderson; Ahmed Hamed Salem; Martin Dunbar; Ming Zhu; Franklin Peale; Jeremy A Ross; Lori Gressick; Monali Desai; Su Young Kim; Maria Verdugo; Rod A Humerickhouse; Gary B Gordon; John F Gerecitano
Journal:  J Clin Oncol       Date:  2017-01-17       Impact factor: 44.544

7.  Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins.

Authors:  G M Kasof; L Goyal; E White
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

8.  Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia.

Authors:  Zachary R Hunter; Lian Xu; Guang Yang; Nicholas Tsakmaklis; Josephine M Vos; Xia Liu; Jie Chen; Robert J Manning; Jiaji G Chen; Philip Brodsky; Christopher J Patterson; Joshua Gustine; Toni Dubeau; Jorge J Castillo; Kenneth C Anderson; Nikhil M Munshi; Steven P Treon
Journal:  Blood       Date:  2016-06-14       Impact factor: 22.113

9.  Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.

Authors:  Lian Xu; Zachary R Hunter; Nicholas Tsakmaklis; Yang Cao; Guang Yang; Jie Chen; Xia Liu; Sandra Kanan; Jorge J Castillo; Yu-Tzu Tai; James L Zehnder; Jennifer R Brown; Ruben D Carrasco; Ranjana Advani; Jean M Sabile; Kimon Argyropoulos; M Lia Palomba; Enrica Morra; Alessandra Trojani; Antonino Greco; Alessandra Tedeschi; Marzia Varettoni; Luca Arcaini; Nikhil M Munshi; Kenneth C Anderson; Steven P Treon
Journal:  Br J Haematol       Date:  2015-12-13       Impact factor: 6.998

10.  Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein.

Authors:  W Liu; I Quinto; X Chen; C Palmieri; R L Rabin; O M Schwartz; D L Nelson; G Scala
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606
View more
  10 in total

1.  Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia.

Authors:  Zachary R Hunter; Lian Xu; Nickolas Tsakmaklis; Maria G Demos; Amanda Kofides; Cristina Jimenez; Gloria G Chan; Jiaji Chen; Xia Liu; Manit Munshi; Joshua Gustine; Kirsten Meid; Christopher J Patterson; Guang Yang; Toni Dubeau; Mehmet K Samur; Jorge J Castillo; Kenneth C Anderson; Nikhil C Munshi; Steven P Treon
Journal:  Blood Adv       Date:  2018-11-13

2.  Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells.

Authors:  Tomasz Sewastianik; Maria Luisa Guerrera; Keith Adler; Peter S Dennis; Kyle Wright; Vignesh Shanmugam; Ying Huang; Helen Tanton; Meng Jiang; Amanda Kofides; Maria G Demos; Audrey Dalgarno; Neil A Patel; Anwesha Nag; Geraldine S Pinkus; Guang Yang; Zachary R Hunter; Petr Jarolim; Nikhil C Munshi; Steven P Treon; Ruben D Carrasco
Journal:  Blood Adv       Date:  2019-11-12

3.  Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemia.

Authors:  Cristina Jiménez; Gloria G Chan; Lian Xu; Nickolas Tsakmaklis; Amanda Kofides; Maria G Demos; Jiaji Chen; Xia Liu; Manit Munshi; Guang Yang; Jorge J Castillo; Adrian Wiestner; Ramón García-Sanz; Steven P Treon; Zachary R Hunter
Journal:  Br J Haematol       Date:  2020-02-27       Impact factor: 6.998

Review 4.  Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies.

Authors:  Steven P Treon; Lian Xu; Maria Luisa Guerrera; Cristina Jimenez; Zachary R Hunter; Xia Liu; Maria Demos; Joshua Gustine; Gloria Chan; Manit Munshi; Nicholas Tsakmaklis; Jiaji G Chen; Amanda Kofides; Romanos Sklavenitis-Pistofidis; Mark Bustoros; Andrew Keezer; Kirsten Meid; Christopher J Patterson; Antonio Sacco; Aldo Roccaro; Andrew R Branagan; Guang Yang; Irene M Ghobrial; Jorge J Castillo
Journal:  J Clin Oncol       Date:  2020-02-21       Impact factor: 44.544

Review 5.  Time to Move to the Single-Cell Level: Applications of Single-Cell Multi-Omics to Hematological Malignancies and Waldenström's Macroglobulinemia-A Particularly Heterogeneous Lymphoma.

Authors:  Ramón García-Sanz; Cristina Jiménez
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

6.  Genomic landscape of Waldenström's macroglobulinemia.

Authors:  Steven P Treon; Zachary R Hunter; Andrew R Branagan; Jorge J Castillo
Journal:  Hemasphere       Date:  2019-06-30

Review 7.  Nucleic Acid Biomarkers in Waldenström Macroglobulinemia and IgM-MGUS: Current Insights and Clinical Relevance.

Authors:  Daniela Drandi; Philippe Decruyenaere; Martina Ferrante; Fritz Offner; Jo Vandesompele; Simone Ferrero
Journal:  Diagnostics (Basel)       Date:  2022-04-12

Review 8.  Targeted and cellular therapies in lymphoma: Mechanisms of escape and innovative strategies.

Authors:  Anagha Deshpande; Javier Munoz
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

9.  Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies.

Authors:  Laura Ondrisova; Marek Mraz
Journal:  Front Oncol       Date:  2020-10-26       Impact factor: 6.244

10.  Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma.

Authors:  Sara Rodriguez; Jon Celay; Ibai Goicoechea; Cristina Jimenez; Cirino Botta; Maria-José Garcia-Barchino; Juan-Jose Garces; Marta Larrayoz; Susana Santos; Diego Alignani; Amaia Vilas-Zornoza; Cristina Perez; Sonia Garate; Sarai Sarvide; Aitziber Lopez; Hans-Christian Reinhardt; Yolanda R Carrasco; Isidro Sanchez-Garcia; Maria-Jose Larrayoz; Maria-Jose Calasanz; Carlos Panizo; Felipe Prosper; Jose-Maria Lamo-Espinosa; Marina Motta; Alessandra Tucci; Antonio Sacco; Massimo Gentile; Sara Duarte; Helena Vitoria; Catarina Geraldes; Artur Paiva; Noemi Puig; Ramon Garcia-Sanz; Aldo M Roccaro; Gema Fuerte; Jesus F San Miguel; Jose-Angel Martinez-Climent; Bruno Paiva
Journal:  Sci Adv       Date:  2022-01-19       Impact factor: 14.136
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.